Etiopathogenesis of primary acquired nasolacrimal duct obstruction (PANDO).
Ali MJ.
Prog Retin Eye Res. 2023 Sep;96:101193. doi: 10.1016/j.preteyeres.2023.101193. Epub 2023 Jul 1.
Nasolacrimal duct obstruction as an important cause of epiphora.
Avdagic E, Phelps PO.
Dis Mon. 2020 Oct;66(10):101043. doi: 10.1016/j.disamonth.2020.101043. Epub 2020 Jul 1.
Surgical management of congenital nasolacrimal duct obstruction; one procedure for all versus all procedures for one.
Kashkouli MB, Karimi N, Khademi B.
Curr Opin Ophthalmol. 2019 Sep;30(5):364-371. doi: 10.1097/ICU.0000000000000584.
Treatment of Congenital Nasolacrimal Duct Obstruction.
Nelson LB.
J Pediatr Ophthalmol Strabismus. 2016 Sep 1;53(5):270. doi: 10.3928/01913913-20160829-01.
[Treatment of nasolacrimal duct obstruction from the otorhinolaryngologist's perspective].
Ginzkey C, Mlynski R.
HNO. 2016 Jun;64(6):394-402. doi: 10.1007/s00106-016-0168-0.
Office- or Facility-Based Probing for Congenital Nasolacrimal Duct Obstruction: A Report by the American Academy of Ophthalmology.
Morrison DG, Binenbaum G, Chang MY, Heidary G, Trivedi RH, Galvin JA, Pineles SL.
Ophthalmology. 2021 Jun;128(6):920-927. doi: 10.1016/j.ophtha.2020.10.028. Epub 2020 Dec 24.
Management of congenital nasolacrimal duct obstruction.
Takahashi Y, Kakizaki H, Chan WO, Selva D.
Acta Ophthalmol. 2010 Aug;88(5):506-13. doi: 10.1111/j.1755-3768.2009.01592.x. Epub 2009 Jul 21.
Common management of congenital nasolacrimal duct obstruction.
Nelson LB.
J Pediatr Ophthalmol Strabismus. 2015 Jan-Feb;52(1):12. doi: 10.3928/01913913-20141230-04.
Endoscopy changing the treatment of congenital nasolacrimal duct obstruction.
Schellini SA, Akaishi PMS.
Arq Bras Oftalmol. 2024 May 27;87(3):e20240087. doi: 10.5935/0004-2749.2024-0087. eCollection 2024.
Assessment of Lacrijet monocanalicular intubation for congenital nasolacrimal duct obstruction.
Hamed Azzam S, Hartstein M, Dolmetsch A, Mukari A.
Eur J Ophthalmol. 2022 Nov;32(6):3340-3345. doi: 10.1177/11206721221076941. Epub 2022 Feb 1.
